- Public StagePublicly traded company
Immix Biopharma Funding
$100M
11 round
Immix Biopharma is active in the following markets / industries: biotechnology, health care and pharmaceuticals. The company has secured funding across 1 rounds, totaling in an amount of $100M. Their most recent funding was raised on December 7, 2025.
Funding Rounds
S
$100000000